Categories

·

A season of games. Some played well, some badly, all of them in plain sight.

·

What markets miss when accidental winners arrive in low-inequality, lowly-indebted societies

·

An idle afternoon's chitter-chatter on six reflexes that have outlived their usefulness.

·

The untold story of how contract labs became a pharmaceutical superpower. China didn't just join the drug discovery race; it rewrote the rules.

·

A look at the gap between popular AI narratives and the complex, world-changing reality of recent breakthroughs in materials, health, and logic.

·

A wave of open-source breakthroughs is redefining technology, investment, and geopolitics for the years ahead.

·

Chinese pharma's breakthroughs are upending many important drivers and notions of the whole global healthcare industry

·

History's lens distorts, not clarifies. From South Sea Bubbles to TMT, past patterns empower demagoguery more than analysis, as our piece playfully shows.

·

An exploration of tech's competing narratives—of doom and boom, stars and systems—viewed in the festive light of Diwali to find the quiet truth in the middle

·

Innovation investment requires embracing complexity, awaiting robust evidence, and testing for endurance.